Further analysis of the tumor infiltrate also showed that the combination of p-Tvax and OX40 agonists produced other effects that may favor tumor clearance such as the reduced expression of the T cell exhaustion marker PD-1 in CD4+ T cells and the decrease in number of Tregs. This evidence concerns the gene TNFRSF4 and neoplasm.